KRISTIN KOHLER: Open Payments
NPI 1366765679 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 22 payments from 12 companies in 2025. Trend: 2023 $401 · 2024 $462 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $91 |
| ABBVIE INC. | 3 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Novocure Inc. | 1 | $33 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Eisai Inc. | 1 | $27 |
| AngioDynamics, Inc. | 1 | $23 |
Products named: CREON, LIBTAYO, KISQALI, CALQUENCE, ELAHERE, Optune Lua (NovoTTF-200T), TECVAYLI, Nubeqa.
Industry payments across MD — which companies pay providers there.
